kr236.40
+ kr1.70 (0.72%)
End-of-day quote: 06/30/2022
OM:GETI B

Getinge AB (GETI B)

Getinge AB provides products and solutions for operating rooms, intensive-care units, sterilization departments, and life science companies and institutions.

If you are interested in GETI B stock information, you might also be interested in competitors like NYSE:EW.

The market capitalization of Getinge AB is currently at kr64.39 B. This places it among the high capitalized companies.

The book value reported in the balance sheet results in a P/B ratio of 2.73.

With one share of Getinge AB investors achieved a dividend of kr4.02. This results in a very low dividend yield of 1.70%. In the last 14 years, the annual dividend has risen constantly.

For the risk analysis, the low beta factor should be noted, which is currently at a value of 0.43. The price of the stock OM:GETI B is therefore subject to moderate fluctuations in relation to the overall market.

20.18% of GETI B Stocks is owned by insiders.

For Wall Street analysts, a price target of kr349.27 is currently considered realistic.

OM:GETI B has a 52 week range of kr181.20 - kr431.60 and is currently trading around kr236.40.

The low short sale ratio indicated that the value might increase in the foreseeable future.

2
Underperform
1
2
3
4
5
6
7
8
9
10
1M 3M YTD 1Y 2Y 5Y 10Y 20Y
P/E Ratio
18.1
Market Cap
64.39B
LT Debt/Cap
0.02%
Price-to-book Ratio
2.73
Earnings
07/19/2022
Dividend
kr4.02
Div Yld
1.70%
Dividend Growth
14 Years
Beta
0.43
Short Interest
0.00%
Forecast 1Y
-44.07%
Analyst Price Target
kr349.27
LTG 5Y
7.66%
52 week range
kr181.20 - kr431.60
Country